Lazard Asset Management’s Twist Bioscience TWST Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.14M | Sell |
58,311
-837
| -1% | -$30.8K | ﹤0.01% | 994 |
|
|
2025
Q1 | $2.32M | Buy |
59,148
+31,267
| +112% | +$1.23M | ﹤0.01% | 920 |
|
|
2024
Q4 | $1.3M | Buy |
27,881
+7,827
| +39% | +$364K | ﹤0.01% | 1040 |
|
|
2024
Q3 | $905K | Buy |
20,054
+15,257
| +318% | +$689K | ﹤0.01% | 1122 |
|
|
2024
Q2 | $235K | Buy |
+4,797
| New | +$235K | ﹤0.01% | 1510 |
|
|
2023
Q1 | – | Sell |
-1,498
| Closed | -$35K | – | 2563 |
|
|
2022
Q4 | $35K | Sell |
1,498
-3,047
| -67% | -$71.2K | ﹤0.01% | 1960 |
|
|
2022
Q3 | $160K | Buy |
4,545
+1,877
| +70% | +$66.1K | ﹤0.01% | 1324 |
|
|
2022
Q2 | $93K | Buy |
2,668
+1,071
| +67% | +$37.3K | ﹤0.01% | 1533 |
|
|
2022
Q1 | $78K | Buy |
1,597
+676
| +73% | +$33K | ﹤0.01% | 1516 |
|
|
2021
Q4 | $71K | Buy |
921
+70
| +8% | +$5.4K | ﹤0.01% | 1582 |
|
|
2021
Q3 | $91K | Sell |
851
-49
| -5% | -$5.24K | ﹤0.01% | 1450 |
|
|
2021
Q2 | $119K | Buy |
+900
| New | +$119K | ﹤0.01% | 1303 |
|
|
2021
Q1 | – | Sell |
-1,358
| Closed | -$191K | – | 2032 |
|
|
2020
Q4 | $191K | Sell |
1,358
-645
| -32% | -$90.7K | ﹤0.01% | 1105 |
|
|
2020
Q3 | $152K | Sell |
2,003
-633
| -24% | -$48K | ﹤0.01% | 986 |
|
|
2020
Q2 | $119K | Sell |
2,636
-1,993
| -43% | -$90K | ﹤0.01% | 982 |
|
|
2020
Q1 | $141K | Buy |
4,629
+3,556
| +331% | +$108K | ﹤0.01% | 947 |
|
|
2019
Q4 | $22K | Buy |
+1,073
| New | +$22K | ﹤0.01% | 1211 |
|